Study: New way to control inflammation

Oct 03, 2006

U.S. researchers say they've discovered a new way to control or terminate potentially harmful immune responses that produce inflammation.

Immune responses defend against invading pathogens and eliminate dangerous tumor cells, for example, but once the threat has been destroyed, the immune responses must end. If left uncontrolled, immune activity can cause autoimmune conditions in which the immune system attacks healthy tissues of the body.

The immune system uses many strategies to shut down immune responses, one of which is signaling cells to die. Now Charles Serhan and colleagues at Harvard University Medical School have demonstrated in mice and humans that dying immune cells express a surface protein that allows them to act as sponges, effectively removing factors that would otherwise promote inflammation.

The scientists say their findings highlight a previously unappreciated role of dying immune cells -- potentially offering a strategy for dampening chronic inflammatory conditions by tricking the immune response to terminate the process.

The report appears in this week's issue of the journal Nature Immunology.

Copyright 2006 by United Press International

Explore further: Team finds key signaling pathway in cause of preeclampsia

add to favorites email to friend print save as pdf

Related Stories

Comcast wins more Internet customers, ad sales up

38 minutes ago

Comcast Corp.'s third-quarter net income jumped 50 percent in the third quarter, helped by a one-time tax settlement, growth in Internet subscribers and fewer defectors from its cable service.

Helping sweet cherries survive the long haul

42 minutes ago

A new study says that cherry producers need to understand new intricacies of the production-harvest-marketing continuum in order to successfully move sweet cherries from growers to end consumers. For example, the Canadian ...

Christian Bale to play Apple's Steve Jobs

57 minutes ago

Oscar-winner Christian Bale—best known for his star turn as Batman in the blockbuster "Dark Knight" films—will play Apple co-founder Steve Jobs in an upcoming biopic.

Netflix to stream new online TV series, 'Bloodline'

58 minutes ago

Fresh from commercial and critical success with hit shows "House of Cards" and "Orange is the New Black," Netflix on Thursday announced a new online series, "Bloodline," set for release in March.

YEATS protein potential therapeutic target for cancer

58 minutes ago

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Recommended for you

Team finds key signaling pathway in cause of preeclampsia

1 hour ago

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

5 hours ago

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 0